Junfeng Liu

1.3k total citations
46 papers, 745 citations indexed

About

Junfeng Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Junfeng Liu has authored 46 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Junfeng Liu's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (8 papers) and RNA modifications and cancer (7 papers). Junfeng Liu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (8 papers) and RNA modifications and cancer (7 papers). Junfeng Liu collaborates with scholars based in China, Australia and United States. Junfeng Liu's co-authors include Chun Chen, Weimin Mao, Shidong Xu, Yi Shen, Xiaofei Li, Heng Zhao, Yongyu Liu, Dongsheng Yue, Yue Yang and Lanjun Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.

In The Last Decade

Junfeng Liu

44 papers receiving 736 citations

Peers

Countries citing papers authored by Junfeng Liu

Since Specialization

Citations

This map shows the geographic impact of Junfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Liu more than expected).

Fields of papers citing papers by Junfeng Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Liu. The network helps show where Junfeng Liu may publish in the future.

Co-authorship network of co-authors of Junfeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Liu. A scholar is included among the top collaborators of Junfeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Liu. Junfeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Characteristics and Disease Course of Livedoid Vasculopathy: A 10-Year Retrospective Analysis 2025 ·Clinical Cosmetic and Investigational Dermatology ·Yali Gao, Yaling Li, (unknown), Haibo Wu, Junfeng Liu, (unknown), Hui Zhou	0
2	Correlation Between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma 2024 ·Annals of Surgical Oncology ·Junhong Liu, (unknown), Zhihua Shi, (unknown), Junfeng Liu	1
3	Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma 2023 ·ACS Applied Materials & Interfaces ·Junfeng Liu, Xi Li, (unknown), Xiaoting Zhang, (unknown), (unknown), Chaoming Mei, (unknown), Chao Peng, Junbin Liu, Xiaojun Hu, Ke Zhang, Dan Li, Bin Zhou	32
4	PKNOX2 suppresses lung cancer cell proliferation by inhibiting the PI3K/AKT/mTOR axis 2023 ·Experimental and Therapeutic Medicine ·(unknown), Nan Zhang, (unknown), Junfeng Liu	4
5	One-stage VATS surgery for synchronous bilateral lung lesion: a safe and feasible procedure 2023 ·Journal of Cardiothoracic Surgery ·Zhe Wang, Xue Zhang, (unknown), Junfeng Liu	2
6	Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer 2022 ·Journal of Clinical Oncology ·Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Zhenfa Zhang, Bin Zhang, Changli Wang	37
7	Effect of taking aspirin before diagnosis on the prognosis of esophageal squamous cell carcinoma and analysis of prognostic factors 2022 ·Journal of International Medical Research ·(unknown), Junfeng Liu, Ping Gao, Junying Liu	2
8	Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching 2022 ·Frontiers in Immunology ·(unknown), (unknown), Wei Zhang, Ming He, (unknown), Ji‐Fang Yao, Rui Wang, (unknown), Jun Wang, Junfeng Liu	28
9	The effectiveness and safety of lienal polypeptide combined with chemotherapy or chemoradiotherapy for non-small cell lung cancer patients in real world 2021 ·Medicine ·(unknown), Junfeng Liu	1
10	The application analysis of 8F ultrafine chest drainage tube for thoracoscopic lobectomy of lung cancer 2021 ·Journal of Cardiothoracic Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), Jianxun Wang, Wenhao Wang, Lijun Liu, Junfeng Liu	5
11	<p>Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial</p> 2020 ·Cancer Management and Research ·Yutao Liu, Xuezhi Hao, Deruo Liu, Gang Cheng, Shucai Zhang, Wenhua Xiao, Yi Hu, Junfeng Liu, Ming He, Cuimin Ding, Li Zhang, Jun Wang, Hui Li, (unknown), Xiuyi Zhi, Jian Li, Yuankai Shi	9
12	MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2 2019 ·Bioengineered ·Feng Gao, Hao Wu, Rui Wang, Yang Guo, Zefeng Zhang, Tao Wang, Guoliang Zhang, Changjiang Liu, Junfeng Liu	51
13	Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial 2018 ·The Lancet Respiratory Medicine ·Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Changli Wang	177
14	TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway 2016 ·Oncology Reports ·Baoen Shan, (unknown), Junfeng Liu, Ling Wang, Tienian Zhu, Ming Ma, (unknown), Xinran Chen, (unknown), Pengfei Li	46
15	Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells 2015 ·Cancer Biology & Therapy ·Qiang Zhen, Junfeng Liu, Jia Liu, Renfeng Wang, Weiwei Chu, Yaxiao Zhang, (unknown), Xiaojian Zhao, Baolei Lv	13
16	MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer 2015 ·Cytogenetic and Genome Research ·Qiang Zhen, Junfeng Liu, Lina Gao, Jia‐Bao Liu, Renfeng Wang, Weiwei Chu, Yaxiao Zhang, (unknown), Xiaojian Zhao, Baolei Lv	55
17	Expression of serotonin receptors in human lower esophageal sphincter 2014 ·Experimental and Therapeutic Medicine ·(unknown), Junfeng Liu, Ke Zhang, Yong Feng	3
18	Evidence for the aetiology of human papillomavirus in oesophageal squamous cell carcinoma in the Chinese population: a meta-analysis 2013 ·BMJ Open ·(unknown), Bayzidur Rahman, Zhanhai Gao, Zheng Yang, Iman Ridda, Aye Moa, Anthony T. Newall, Holly Seale, Qian Li, Junfeng Liu, C. Raina MacIntyre	12
19	Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter 2013 ·Experimental and Therapeutic Medicine ·Yong Feng, Junfeng Liu	4
20	Bronchoplastic and Pulmonary Arterioplastic Procedures in the Treatment of Bronchogenic Carcinoma 2004 ·Asian Journal of Surgery ·Junfeng Liu, Qizhang Wang, (unknown), Yude Zhang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact